Literature DB >> 19892029

Role for endothelial nitric oxide synthase in nitrite-induced protection against renal ischemia-reperfusion injury in mice.

A B Milsom1, N S A Patel, E Mazzon, P Tripatara, A Storey, H Mota-Filipe, B Sepodes, A J Webb, S Cuzzocrea, A J Hobbs, C Thiemermann, A Ahluwalia.   

Abstract

Nitrite is protective against renal ischemia/reperfusion injury (IRI); an effect due to its reduction to nitric oxide (NO). In addition to other reductase pathways, endothelial NO synthase (eNOS) may also facilitate nitrite reduction in ischemic environments. We investigated the role of eNOS in sodium nitrite (60 microM, 10 ml/kg applied topically 1 min before reperfusion)-induced protection against renal IRI in C57/BL6 wild-type (WT) and eNOS knockout (eNOS KO) mice subjected to bilateral renal ischemia (30 min) and reperfusion (24h). Markers of renal dysfunction (plasma [creatinine] and [urea]), damage (tubular histology) and inflammation (cell recruitment) were elevated following IRI in WT mice; effects significantly reduced following nitrite treatment. Chemiluminescence analysis of cortical and medullary sections of the kidney demonstrated rapid (within 1 min) distribution of nitrite following application. Whilst IRI caused a significant (albeit substantially reduced compared to WT mice) elevation of markers of renal dysfunction and damage in eNOS KO mice, the beneficial effects of nitrite were absent or reduced, respectively. Moreover, nitrite treatment enhanced renal dysfunction in the form of increased plasma [creatinine] in eNOS KO mice. Confirmation of nitrite reductase activity of eNOS was provided by demonstration of nitrite (100 microM)-derived NO production by kidney homogenates of WT mice, that was significantly reduced by L-NMMA. L-NMMA was without effect using kidney homogenates of eNOS KO mice. These results support a role for eNOS in the pathways activated during renal IRI and also identify eNOS as a nitrite reductase in ischemic conditions; activity which in part underlies the protective effects of nitrite. (c) 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19892029     DOI: 10.1016/j.niox.2009.10.010

Source DB:  PubMed          Journal:  Nitric Oxide        ISSN: 1089-8603            Impact factor:   4.427


  22 in total

Review 1.  Inorganic nitrite supplementation for healthy arterial aging.

Authors:  Amy L Sindler; Allison E Devan; Bradley S Fleenor; Douglas R Seals
Journal:  J Appl Physiol (1985)       Date:  2014-01-09

2.  The macrophage stimulating anti-cancer agent, RRx-001, protects against ischemia-reperfusion injury.

Authors:  Pedro Cabrales; Scott Caroen; Arnold Oronsky; Corey Carter; Jane Trepel; Thomas Summers; Tony Reid; Neil Oronsky; Michelle Lybeck; Bryan Oronsky
Journal:  Expert Rev Hematol       Date:  2017-05-22       Impact factor: 2.929

Review 3.  Examining and mitigating acellular hemoglobin vasoactivity.

Authors:  Pedro Cabrales
Journal:  Antioxid Redox Signal       Date:  2012-10-11       Impact factor: 8.401

Review 4.  Nitrite in organ protection.

Authors:  Tienush Rassaf; Peter Ferdinandy; Rainer Schulz
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

Review 5.  Blood substitutes: evolution from noncarrying to oxygen- and gas-carrying fluids.

Authors:  Pedro Cabrales; Marcos Intaglietta
Journal:  ASAIO J       Date:  2013 Jul-Aug       Impact factor: 2.872

6.  Nitrite therapy is neuroprotective and safe in cardiac arrest survivors.

Authors:  Cameron Dezfulian; Aleksey Alekseyenko; Kunjan R Dave; Ami P Raval; Rose Do; Francis Kim; Miguel A Perez-Pinzon
Journal:  Nitric Oxide       Date:  2012-03-30       Impact factor: 4.427

7.  Expression of key regulators of mitochondrial biogenesis in growth hormone receptor knockout (GHRKO) mice is enhanced but is not further improved by other potential life-extending interventions.

Authors:  Adam Gesing; Michal M Masternak; Feiya Wang; Anna-Maria Joseph; Christiaan Leeuwenburgh; Reyhan Westbrook; Andrzej Lewinski; Malgorzata Karbownik-Lewinska; Andrzej Bartke
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-07-25       Impact factor: 6.053

8.  Therapeutic potential of sustained-release sodium nitrite for critical limb ischemia in the setting of metabolic syndrome.

Authors:  David J Polhemus; Jessica M Bradley; Kazi N Islam; Luke P Brewster; John W Calvert; Ya-Xiong Tao; Carlos C Chang; Iraklis I Pipinos; Traci T Goodchild; David J Lefer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-04-24       Impact factor: 4.733

9.  Vascular effects of dietary nitrate (as found in green leafy vegetables and beetroot) via the nitrate-nitrite-nitric oxide pathway.

Authors:  Satnam Lidder; Andrew J Webb
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

10.  Impact of chronic congestive heart failure on pharmacokinetics and vasomotor effects of infused nitrite.

Authors:  Abdul R Maher; Sayqa Arif; Melanie Madhani; Khalid Abozguia; Ibrar Ahmed; Bernadette O Fernandez; Martin Feelisch; A G O'Sullivan; Arthur Christopoulos; Aaron L Sverdlov; Doan Ngo; Rustem Dautov; Philip E James; John D Horowitz; Michael P Frenneaux
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.